Rabies Diagnostics Market to Grow with a CAGR of 7.64%through 2028
Increasing Incidence of Rabies are expected to
drive the Global Rabies Diagnostics Market growth in the forecast period,
2024-2028
According to
TechSci Research report, “Rabies Diagnostics Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2028”, the
Global Rabies Diagnostics Market stood at USD 1.96 Billion in 2022 and is
anticipated to grow with a CAGR of 7.64% through 2028. Neglected Tropical
Diseases (NTDs) have afflicted several densely populated and low-resource
setting regions across the globe. One such NTD is Rabies that continues to pose
a significant threat to human and animal health, particularly in Asian and
African countries. Several international healthcare organizations are engaged
in establishing collaboration with healthcare entities for the development and
commercialization of novel detection assays to drive the efforts that target to
combat the disease. For example, the World Health Organization (WHO), in
collaboration with other healthcare agencies, such as provincial health
authorities, is involved in the promotion of research endeavors taken up for
rabies control across the globe. The WHO has also released several documents
illustrating various aspects of a comprehensive control program for this
disease. Such ongoing activities in the rabies testing market are anticipated
to fuel the demand for robust diagnostic solutions. In
2018, LN34 pan-lyssavirus real-time RT-PCR assay was evaluated for its
efficiency in post-mortem rabies diagnostics. This LN34 test is considered to
be simpler and easier to use.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Rabies Diagnostics Market”
The Global Rabies
Diagnostics Market is segmented into diagnostic method, technology method and
company.
Based on the
Diagnostic Method, the Fluorescent Antibody Test (FAT) segment is anticipated
to witness substantial market growth throughout the forecast period. The
Fluorescent Antibody Test (FAT) diagnostic method is poised to be a significant
driver of growth in the Global Rabies Diagnostics Market. FAT, renowned for its
high sensitivity and specificity, is a pivotal tool in the accurate detection
of the rabies virus. This diagnostic method utilizes fluorescently labeled
antibodies to specifically bind to rabies antigens, allowing for visual
confirmation under a fluorescent microscope. The reliability and precision
offered by FAT make it a preferred choice for many healthcare professionals and
veterinary practitioners in confirming rabies cases. Its ability to provide
rapid results enhances the efficiency of diagnostic workflows, facilitating
timely interventions and control measures. Furthermore, as the global emphasis
on rabies prevention and control intensifies, the demand for robust diagnostic
methods like FAT is on the rise. The method's effectiveness in identifying the
virus in various animal species contributes to its widespread adoption.
Based on the
Technology Method segment, the Cardiovascular segment has been the dominant
force in the market. The growth of the Global Rabies Diagnostics Market is
poised to be significantly propelled by the adoption of ELISA (Enzyme-Linked
Immunosorbent Assay) and Immunohistochemistry methods. These sophisticated
diagnostic techniques play a pivotal role in accurately detecting the rabies
virus and have become integral components of modern diagnostic workflows.
ELISA, known for its high sensitivity and specificity, allows for the
quantification of rabies-specific antibodies or antigens, providing reliable
results in a cost-effective and time-efficient manner. Its versatility and
adaptability make it a preferred choice in large-scale diagnostic settings, contributing
to the scalability of rabies testing programs. Immunohistochemistry, on the
other hand, enables the visualization of rabies antigens in tissue samples,
offering valuable insights into the distribution and localization of the virus.
This method enhances diagnostic precision and aids in understanding the
pathology of rabies, guiding appropriate treatment and control measures. The
increasing demand for accurate and efficient rabies diagnostics, driven by
heightened global awareness and regulatory efforts, positions ELISA and
Immunohistochemistry as key drivers of market growth.
Major companies
operating in Global Rabies Diagnostics Market are:
- Bio-Rad
Laboratories, Inc
- Merck KGaA.
- Aviva Systems
Biology Corporation.
- Creative
Diagnostics.
- Demeditec
Diagnostics GmbH.
- Abbexa Ltd.
- Norgen Biotek Corp.
- BioNote, Inc.
- Express Biotech
International Inc.
Download Free Sample Report
Customers can
also request 10% free customization on this report
“The Global
Rabies Diagnostics Market is driven by increasing awareness about rabies
prevention, rising incidence of animal bites, and stringent government initiatives
for rabies control. Technological advancements in diagnostic methods, coupled
with the growing demand for rapid and accurate testing, contribute to market
growth. Additionally, the escalating adoption of point-of-care testing and the
surge in pet ownership further fuel the market. The emphasis on mass
vaccination campaigns and the development of cost-effective diagnostic
solutions are pivotal factors shaping the upward trajectory of the Global
Rabies Diagnostics Market. ” said Mr. Karan Chechi, Research Director with
TechSci Research, a research-based management consulting firm.
“Rabies
Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2018-2028 Segmented By Diagnostic Method (Fluorescent Antibody Test
(FAT), Immunohistochemical Test, Amplification Methods, Histologic Examination,
Serology Tests), By Technology Method (ELISA/Immunohistochemistry,
Chromatography Techniques, PCR, Others), By Region, By Competition”,
has evaluated the future growth potential of Global Rabies Diagnostics Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Rabies Diagnostics Market.
Contact
TechSci
Research LLC
420 Lexington
Avenue, Suite 300,
New York, United
States- 10170
Contact:
+1332258660
Email: [email protected]
Web: www.techsciresearch.com